| Outcomes after treatment with cobimetinib in patients with Rosai-Dorfman disease based on KRAS and MEK alteration status JP Abeykoon, KL Rech, JR Young, A Ravindran, GJ Ruan, S Dasari, ... JAMA oncology 8 (12), 1816-1820, 2022 | 20 | 2022 |
| Latent tuberculosis in hematopoietic stem cell transplantation: diagnostic and therapeutic strategies to prevent disease activation in an endemic population C Bourlon, R Camacho-Hernández, OM Fierro-Angulo, ... Biology of Blood and Marrow Transplantation 26 (7), 1350-1354, 2020 | 18 | 2020 |
| BRAF Fusions in Histiocytic Disorders: Frequency and Clinical Characteristics S Zanwar, JP Abeykoon, AA Acosta-Medina, A Ravindran, K Rech, ... Blood 138, 2582, 2021 | 9* | 2021 |
| BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis AA Acosta-Medina, PG Kemps, TCE Zondag, JP Abeykoon, J Forma-Borst, ... Blood 142 (18), 1570-1575, 2023 | 7 | 2023 |
| Impact of socioeconomic characteristics and comorbidities on therapy initiation and outcomes of newly diagnosed multiple myeloma: real-world data from a resource-constrained … C Vargas-Serafin, AA Acosta-Medina, I Ordonez-Gonzalez, ... Clinical Lymphoma Myeloma and Leukemia 21 (3), 182-187, 2021 | 7 | 2021 |
| Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation AA Acosta-Medina, AM Moyer, RS Go, MAV Willrich, FC Fervenza, ... Blood Advances 7 (3), 340-350, 2023 | 5* | 2023 |
| Classical and non‐classical phenotypes of Erdheim–Chester disease: Correlating clinical, radiographic and genotypic findings. AZ Hazim, AA Acosta‐Medina, JR Young, GJ Ruan, JP Abeykoon, ... British Journal of Haematology 199 (3), 2022 | 5 | 2022 |
| Clinical features and outcomes of non-pulmonary unifocal adult Langerhans cell histiocytosis M Hu, G Goyal, JP Abeykoon, AA Acosta-Medina, GJ Ruan, JR Young, ... Blood cancer journal 12 (6), 89, 2022 | 5 | 2022 |
| Long-term outcomes among adults with Langerhans cell histiocytosis G Goyal, AA Acosta-Medina, JP Abeykoon, C Dai, A Ravindran, ... Blood Advances 7 (21), 6568-6578, 2023 | 4 | 2023 |
| Ophthalmologic involvement in adults with histiocytic disorders: clinical presentation and treatment outcomes SA Banks, MT Bhatti, RS Go, JP Abeykoon, AA Acosta-Medina, AZ Hazim, ... Ophthalmology 130 (1), 77-86, 2023 | 4 | 2023 |
| Induction-related mortality in adolescents and young adults with acute lymphoblastic leukemia in a resource-limited setting: do treatment-related complications create more … SI Inclan-Alarcon, S Riviello-Goya, K Teran-De-la-Sancha, ... Blood research 57 (1), 29, 2022 | 4 | 2022 |
| Oncolytic virotherapy–forging its place in the immunomodulatory paradigm for Multiple Myeloma J Cook, AA Acosta-Medina, KW Peng, M Lacy, S Russell Cancer Treatment and Research Communications 29, 100473, 2021 | 4 | 2021 |
| Isolated extramedullary relapse in acute lymphoblastic leukemia: What can we do before and after transplant? S Riviello-Goya, AA Acosta-Medina, SI Inclan-Alarcon, S Garcia-Miranda, ... Oncology (Williston Park, NY) 34 (2), 39-43, 2020 | 4 | 2020 |
| Impact of additional cytogenetic abnormalities on the clinical behavior of patients with chronic myeloid leukemia: report on a Latin American population K Morales-Chacón, C Bourlon, AA Acosta-Medina, MT Bourlon, A Aguayo, ... Clinical Lymphoma Myeloma and Leukemia 19 (6), e299-e306, 2019 | 4 | 2019 |
| Comparison of Pretransplantation prediction models for nonrelapse mortality in patients with myelofibrosis undergoing allogeneic stem cell transplantation AA Acosta-Medina, A Baranwal, IMK Johnson, MA Kharfan-Dabaja, ... Transplantation and Cellular Therapy 29 (6), 360. e1-360. e8, 2023 | 3 | 2023 |
| Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma AA Acosta-Medina, IMK Johnson, R Bansal, M Hathcock, SJ Kenderian, ... Blood cancer journal 13 (1), 7, 2023 | 3 | 2023 |
| HIV-positive patients presenting with peripheral blood cytopenias: is bone marrow assessment a priority? S Rajme-Lopez, B Crabtree-Ramírez, AA Acosta-Medina, ... Hematology, Transfusion and Cell Therapy 44, 542-548, 2022 | 3 | 2022 |
| Outcomes and challenges of reproductive health in hematopoietic stem cell transplantation survivors C Bourlon, S Riviello-Goya, AA Acosta-Medina, RE Caballero-Landinez, ... Biology of Blood and Marrow Transplantation 26 (11), 2127-2131, 2020 | 2* | 2020 |
| BRAF testing modalities in histiocytic disorders: Comparative analysis and proposed testing algorithm AA Acosta-Medina, JP Abeykoon, RS Go, G Goyal, A Ravindran, ... American Journal of Clinical Pathology 160 (5), 483-489, 2023 | 1 | 2023 |
| Acute leukemia relapse after hematopoietic stem cell transplantation: the good, the bad, and the ugly of isolated extramedullary relapse in a Latin American population L Arias-Espinosa, AA Acosta-Medina, A Vargas-España, ... Transplantation and Cellular Therapy 29 (8), 510. e1-510. e9, 2023 | 1 | 2023 |
RONALD S. GO MDMayo ClinicVerified email at mayo.edu
